Browsing Institute Director's Office by Author "Dinkova-Kostova, AT"
Now showing items 1-1 of 1
-
Investigation into the use of histone deacetylase inhibitor MS-275 as a topical agent for the prevention and treatment of cutaneous squamous cell carcinoma in an SKH-1 hairless mouse model.
Kalin, JH; Eroglu, A; Liu, H; Holtzclaw, WD; Leigh, I; Proby, CM; Fahey, JW; Cole, PA; Dinkova-Kostova, AT (2019)Cutaneous squamous cell carcinomas are a common form of highly mutated keratinocyte skin cancers that are of particular concern in immunocompromised patients. Here we report on the efficacy of topically applied MS-275, a ...